Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 899

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 899
---
 RMC Co. Ltd. (“ RMC”); •reviewed comparable public and privately-held company analysis provided by the M&A Committee; •researched and analyzed recent deal activities in the biopharma field (i.e., asset, equity, tech access, collaboration, license deals) which are relevant to the assets, companies and business model of OSR; •researched and analyzed materials concerning sales analogs of marketed drugs specific to the assets, companies and business model of OSR; Annex I-2 •reviewed and analyzed data rooms content made available by OSR, containing on a per company, per asset basis, information related to scientific, IP, business model, competitive landscape, R&D and financial assumptions and capitalization table to date; •interviewed certain members of the management of OSR regarding the business, operations, financial conditions and prospects of OSR and its subsidiaries; •considered publicly available financial terms of certain transactions that we deemed to be relevant; and •conducted such other tests, analysis and inquiries, as we deemed necessary and appropriate under the circumstances. We have relied upon and assumed, without independent verification, the accuracy, good faith and completeness of all data, material or other information furnished, or otherwise made available to us, discussed with or reviewed by us, or publicly available, and do not assume any responsibility with respect to such data, material, and other information. In addition, we assume that the information supplied by management of OSR and others represented a good faith effort to describe OSR’s subsidiaries and assets. We have relied upon and assumed, without independent verification, that: •the representations and warranties of all parties to the Business Combination Agreement and all related documents and instruments are true and correct; •each party to the Business Combination Agreement will fully and timely perform all of the covenants and agreements required to be performed by such party; •all conditions to the consummation of the Transaction will be satisfied without waiver thereof; •the Transaction will be consummated in a timely manner in accordance with the Business Combination Agreement; •the Transaction will be consummated in a manner that complies in all respects with all applicable federal and state statutes, rules, and regulations; and •all governmental, regulatory, and other consents and approvals necessary for the consummation of the Transaction will be obtained and that no delay, limitations, restrictions, or conditions will be imposed, or amendments, modifications or waivers made that would have an effect on the Transaction or on OSR that would be material to